Sumatriptan Succinate

CAS 103628-48-4 13 current records 3 historicalSmall Molecule

Who holds supplier records for Sumatriptan Succinate? 13 organisations hold a current record for Sumatriptan Succinate: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (10) and Spain (2); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Sumatriptan Succinate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/sumatriptan-succinate

Reading the evidence

  • 13 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    10 of the 12 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 9 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (13)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Sumatriptan Succinate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India10Spain2Country not recorded for 1
Need Sumatriptan Succinate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (10)

Certificates of Suitability on the EDQM register for Sumatriptan Succinate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 19 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2023-022 - Rev 02
Sumatriptan succinate, Process II
Sept 2026—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2016-134 - Rev 03
Sumatriptan succinate, Benzoate route
May 2026—
NOSCH LABS PRIVATE LIMITED HyderabadIN
CEP 2024-042 - Rev 01
Sumatriptan succinate
May 2026—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2009-156 - Rev 04
Sumatriptan succinate
Sept 2025—
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
CEP 2009-139 - Rev 02
Sumatriptan succinate
Aug 2025—
MSN PHARMACHEM PRIVATE LIMITED Sangareddy DistrictIN
CEP 2009-096 - Rev 05
Sumatriptan succinate, Micronised and Non-micronised
Dec 2024—
CHROMO LABORATORIES INDIA PRIVATE LIMITED PashamylaramIN
CEP 2022-292 - Rev 00
Sumatriptan succinate
Sept 2024—
QUIMICA SINTETICA S.A. Alcala De HenaresES
R1-CEP 2001-089 - Rev 01
Sumatriptan succinate
May 2020—
SMS PHARMACEUTICALS LIMITED HyderabadIN
R1-CEP 2007-329 - Rev 05
Sumatriptan succinate, Alternative synthesis
Sept 2019—
NATCO PHARMA LIMITED HyderabadIN
R1-CEP 2003-245 - Rev 03
Sumatriptan succinate
Feb 2017—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (3)

Organisations whose Type II DMFs for Sumatriptan Succinate are no longer active. These show a past filing, not current supply.

Show all 3 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Sumatriptan Succinate is a selective serotonin receptor agonist used primarily in the treatment of migraine attacks. It functions by narrowing blood vessels in the brain, stopping pain signals, and affecting other substances that can trigger migraine symptoms.

Chemical identity

IUPAC name
butanedioic acid;1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide
Canonical SMILES
CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O
InChIKey
PORMUFZNYQJOEI-UHFFFAOYSA-N
Synonyms
Imitrex API, gr 43175c, gr-43175c, nsc-760362, onzetra xsail, sumatriptan (as succinate), sumatriptan galpharm, treximet, treximet component sumatriptan succinate, zembrace symtouch

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Serotonin-1b and Serotonin-1d Receptor Agonist
Mechanism of action
Serotonin 1b Receptor Agonists; Serotonin 1d Receptor Agonists

Therapeutic areas

MigraineHeadache DisordersNeurology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Sumatriptan Succinate?

13 organisations hold an active US FDA Type II Drug Master File or a CEP for Sumatriptan Succinate: APITORIA PHARMA PRIVATE LTD (India), Dr. Reddy's Laboratories Ltd. (India), Natco Pharma (India), CHROMO LABORATORIES INDIA PRIVATE LTD (India), MATRIX PHARMACORP PRIVATE LTD (India), MSN PHARMACHEM PRIVATE LTD (India), QUIMICA SINTETICA SA (Spain) and SMS Pharmaceuticals limited (India), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Sumatriptan Succinate Drug Master Files are active?

APITORIA PHARMA PRIVATE LTD (DMF 19330, 32218), Dr. Reddy's Laboratories Ltd. (DMF 37551, 16534), Natco Pharma (DMF 20894, 16930), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 36972), MATRIX PHARMACORP PRIVATE LTD (DMF 21711), MSN PHARMACHEM PRIVATE LTD (DMF 22482), QUIMICA SINTETICA SA (DMF 15376) and SMS Pharmaceuticals limited (DMF 16279, 20746) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Sumatriptan Succinate records mean?

3 organisations have only inactive Type II DMFs for Sumatriptan Succinate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Sumatriptan Succinate have a European Certificate of Suitability?

Yes. 10 organisations hold a valid CEP for Sumatriptan Succinate on the EDQM register, including DR. REDDY'S LABORATORIES LIMITED Hyderabad (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), NOSCH LABS PRIVATE LIMITED Hyderabad (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN) and MSN PHARMACHEM PRIVATE LIMITED Sangareddy District (IN) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Sumatriptan Succinate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Sumatriptan Succinate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.